Stanford Bio-X Poster Session
JOIN US FOR A STANFORD BIO-X POSTER SESSION!
-
-
Beyond Editing: How to Explore and Engineer a Living Genome Using Dead CRISPR Molecules
Stanford Bio-X Frontiers in Interdisciplinary Biosciences Seminar
STANLEY QI, DEPARTMENTS OF BIOENGINEERING AND CHEMICAL & SYSTEMS BIOLOGY
Dr. Qi is a pioneer in the CRISPR technology development for genome engineering. His research laboratory focuses on the bioengineering of genetics and cells. They are interested in developing genetic engineering technologies and exploring discovery-based synthetic biology for diverse applications, and explore how the human genome encodes functions, and how to rationally design genetic circuits for new therapeutics.
-
A View into the 'Century of Biology' and Agilent
Stanford Bio-X Frontiers in Interdisciplinary Biosciences Seminar
Dr. Darlene Solomon is senior vice president and chief technology officer for Agilent Technologies. Her responsibilities include Agilent Research Laboratories which focuses on high impact, longer range research in support of Agilent's sustained business growth, and Agilent's programs in university relations, external research and venture investment. In her leadership role, she works closely with Agilent's businesses to define the company's technology strategy and R&D priorities.
-
Frontiers in Quantitative Biology Seminar
Frontiers in Quantitative Biology Seminar
The Ünal lab studies the principles that control the nuclear and cytoplasmic integrity of gametes. They are interested in understanding the principles and regulation of meiotic differentiation.
-
Application Deadline: 2019 Bio-X Undergraduate Summer Research Program
Stanford Bio-X would like to announce our call for applications for the Undergraduate Summer Research Program with funding available starting in the summer of 2019 (June 24th through August 30th).
Complete applications must be received, not postmarked, by December 7, 2018 at 5:00 pm PST.
-
Frontiers in Quantitative Biology Seminar
Frontiers in Quantitative Biology Seminar
AMY GLADFELTER, UNIVERSITY OF NORTH CAROLINA
The Gladfelter lab is interested in how cells are organized in time and space. They study how cytoplasm is spatially patterned and how cells sense their own shape. They also investigate how timing in the cell division cycle can be highly variable yet still accurate. For their work, we combine quantitative live cell microscopy and computational, genetic and biochemical approaches in fungal and mammalian cells.
-
CANCELED: Molecular insights into psychoactive drug actions
Stanford bio-X Frontiers in Interdisciplinary Biosciences Seminar
BRYAN ROTH, UNIVERSITY OF NORTH CAROLINA
This seminar has been canceled. Please join us for future seminars.
-
Stanford Bio-X Frontiers in Interdisciplinary Biosciences Pre-Seminar
Stanford Bio-X Frontiers in Interdisciplinary Biosciences Pre-Seminar
RON DROR, DEPARTMENT OF COMPUTER SCIENCE
Attend Dr. Dror's pre-seminar presentation to learn more about Dr. Bryan Roth's seminar, "Molecular insights into psychoactive drug actions", to be held Thursday, November 15th.
-
Powering Innovation through academia-industry cross-talk
Stanford Bio-X Frontiers in Interdisciplinary Biosciences Seminar
SYLVAINE CASES, JOHNSON & JOHNSON INNOVATION
Dr. Cases's is the Vice President of Oncology Scientific Innovation at Johnson & Johnson Innovation in California. She has significant experience in the fields of cancer biology and metabolism, with more than 16 years in research and drug discovery in both pharma and biotech.
-
From Bio-X to BioSTAR and beyond – the SPARK at Stanford way. Finding a path to developing a treatment for neurodegenerative diseases
Stanford bio-X Frontiers in Interdisciplinary Biosciences Seminar
DARIA MOCHLY-ROSEN, DEPARTMENT OF CHEMICAL & SYSTEMS BIOLOGY
Dr. Daria Mochly-Rosen founded the SPARK program to provide a cost-effective model to generate proof of concept using industry standards. Since 2006, SPARK has advanced scores of new diagnostics and drugs to the clinic and commercial sectors and educated hundreds of faculty, postdoctoral fellows, and students on the translational process. Dr. Mochly-Rosen's research lab is a multi-disciplinary lab that includes chemists, biochemists, biologists and physician scientists. They develop pharmacological agents and apply them to understand molecular and cellular events under basal and disease conditions using in vitro, in culture and in vivo models.